Reversal of Anticoagulation Effect of Dabigatran with Idarucizumab, for Thrombolysis in Acute Ischemic Stroke: Inimicus Inimico Amicus

被引:7
|
作者
Maramattom, Boby V. [1 ]
Thomas, Joe [2 ]
机构
[1] Aster Medcity, Dept Neurol, Kochi, Kerala, India
[2] Aster Medcity, Kochi, Kerala, India
关键词
D O I
10.4103/aian.AIAN_536_18
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:515 / +
页数:3
相关论文
共 50 条
  • [41] Intravenous thrombolysis after reversal of dabigatran by idarucizumab: a moment to be a pioneer
    Turine, G.
    Peeters, A.
    Hermans, C.
    Eeckhoudt, S.
    Duprez, T.
    ACTA NEUROLOGICA BELGICA, 2017, 117 (03) : 753 - 755
  • [42] Intravenous thrombolysis after reversal of dabigatran by idarucizumab: a moment to be a pioneer
    G. Turine
    A. Peeters
    C. Hermans
    S. Eeckhoudt
    T. Duprez
    Acta Neurologica Belgica, 2017, 117 : 753 - 755
  • [43] Immediate Reversal of Dabigatran by Idarucizumab Prior to Laboratory and Imaging Results in Acute Stroke
    Hieber, Maren
    Bardutzky, Juergen
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [44] Reversal of dabigatran with idarucizumab in hyperacute stroke: a new paradigm?
    Ting, Amy
    Venkat, Abhay R.
    Gawarikar, Yash
    Patel, Ronak
    MEDICAL JOURNAL OF AUSTRALIA, 2019, 210 (07) : 302 - +
  • [45] Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen Activator
    Bissig, David
    Manjunath, Rashmi
    Traylor, Brittany R.
    Richman, David P.
    Ng, Kwan L.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2017, 26 (06): : E102 - E104
  • [46] Intravenous Thrombolysis After Dabigatran Reversal by Idarucizumab: A Systematic Review of the Literature
    Frol, Senta
    Sagris, Dimitrios
    Pretnar Oblak, Janja
    Sabovic, Miso
    Ntaios, George
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [47] "Reversal" of dabigatran-induced anticoagulation with idarucizumab: experience of an Italian hospital
    Diani, Erika
    Giampreti, Andrea
    Lerede, Teresa
    Marchetti, Marina
    Gualandris, Federica
    Barcella, Luca
    Eleftheriou, Georgios
    Gallo, Mariapina
    Faraoni, Lorella
    Contessa, Maria Gioia
    Butera, Raffaella
    Bacis, Giuseppe
    Falanga, Anna
    CLINICAL TOXICOLOGY, 2021, 59 (06) : 560 - 560
  • [48] Reversing dabigatran effect with idarucizumab to enable intravenous thrombolysis in patients with acute ischaemic stroke - a single centre experience
    Wlodarczyk, Ewa
    Sawczynska, Katarzyna
    Wrona, Pawel
    Slowik, Agnieszka
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2023, 57 (06) : 465 - 476
  • [49] Reversal of dabigatran using idarucizumab: single center experience in four acute stroke patients
    Hieber, Maren
    Hollasch, Heiko
    Heck, Dorothee
    Maechtel, Mirjam
    Geisen, Ulrich
    Niesen, Wolf-Dirk
    Brich, Jochen
    Harloff, Andreas
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 46 (01) : 12 - 15
  • [50] Reversal of dabigatran using idarucizumab: single center experience in four acute stroke patients
    Maren Hieber
    Heiko Hollasch
    Dorothee Heck
    Mirjam Mächtel
    Ulrich Geisen
    Wolf-Dirk Niesen
    Jochen Brich
    Andreas Harloff
    Journal of Thrombosis and Thrombolysis, 2018, 46 : 12 - 15